New Approaches to Drug Policies

New Approaches to Drug Policies
Author: Jonathan D. Rosen
Publisher: Springer
Total Pages: 227
Release: 2015-07-27
Genre: Social Science
ISBN: 1137450991

The US-led war on drugs has failed: drugs remain purer, cheaper and more readily available than ever. Extreme levels of violence have also grown as drug traffickers and organized criminals compete for control of territory. This book points towards a number of crucial challenges, policy solutions and alternatives to the current drug strategies.

New Approaches to Drug Policies

New Approaches to Drug Policies
Author: Jonathan D. Rosen
Publisher: Springer
Total Pages: 268
Release: 2015-07-27
Genre: Social Science
ISBN: 1137450991

The US-led war on drugs has failed: drugs remain purer, cheaper and more readily available than ever. Extreme levels of violence have also grown as drug traffickers and organized criminals compete for control of territory. This book points towards a number of crucial challenges, policy solutions and alternatives to the current drug strategies.

Drugs and Drug Policy

Drugs and Drug Policy
Author: Mark A.R. Kleiman
Publisher: Oxford University Press
Total Pages: 258
Release: 2011-07-13
Genre: Political Science
ISBN: 0199831386

While there have always been norms and customs around the use of drugs, explicit public policies--regulations, taxes, and prohibitions--designed to control drug abuse are a more recent phenomenon. Those policies sometimes have terrible side-effects: most prominently the development of criminal enterprises dealing in forbidden (or untaxed) drugs and the use of the profits of drug-dealing to finance insurgency and terrorism. Neither a drug-free world nor a world of free drugs seems to be on offer, leaving citizens and officials to face the age-old problem: What are we going to do about drugs? In Drugs and Drug Policy, three noted authorities survey the subject with exceptional clarity, in this addition to the acclaimed series, What Everyone Needs to Know®. They begin, by defining "drugs," examining how they work in the brain, discussing the nature of addiction, and exploring the damage they do to users. The book moves on to policy, answering questions about legalization, the role of criminal prohibitions, and the relative legal tolerance for alcohol and tobacco. The authors then dissect the illicit trade, from street dealers to the flow of money to the effect of catching kingpins, and show the precise nature of the relationship between drugs and crime. They examine treatment, both its effectiveness and the role of public policy, and discuss the beneficial effects of some abusable substances. Finally they move outward to look at the role of drugs in our foreign policy, their relationship to terrorism, and the ugly politics that surround the issue. Crisp, clear, and comprehensive, this is a handy and up-to-date overview of one of the most pressing topics in today's world. What Everyone Needs to Know® is a registered trademark of Oxford University Press.

European Drug Policies

European Drug Policies
Author: Renaud Colson
Publisher: Routledge
Total Pages: 369
Release: 2017-01-27
Genre: Law
ISBN: 1317426940

The drug control regime established by the international community has not succeeded in curbing either the demand for, or the offer of, narcotics. But, despite a series of developments in the Americas – including the legalisation of cannabis in Uruguay and in several states in the United States of America – there is still little support in Europe for repealing drug-prohibition laws. Nevertheless, a gradual policy convergence reveals the emergence of a European model favouring public-health strategies over a strictly penal approach to combatting drugs, while growing transnational support for legalisation indicates the persistence of an alternative paradigm for drug policy. This book examines the various influences on drug policies in Europe, as grassroots movements, NGO networks, private foundations and academic research centres increasingly confront the prevailing discourses of drug prohibition. Pursuing an interdisciplinary approach and bringing together legal scholars, social scientists and practitioners, it provides a comprehensive and critical assessment of drug policy reform in Europe.

Treating Drug Problems:

Treating Drug Problems:
Author: Committee for the Substance Abuse Coverage Study
Publisher: National Academies Press
Total Pages: 332
Release: 1992-01-01
Genre: Medical
ISBN: 9780309043960

Treating Drug Problems, Volume 2 presents a wealth of incisive and accessible information on the issue of drug abuse and treatment in America. Several papers lay bare the relationship between drug treatment and other aspects of drug policy, including a powerful overview of twentieth century narcotics use in America and a unique account of how the federal government has built and managed the drug treatment system from the 1960s to the present. Two papers focus on the criminal justice system. The remaining papers focus on Employer policies and practices toward illegal drugs. Patterns and cycles of cocaine use in subcultures and the popular culture. Drug treatment from a marketing, supply-and-demand perspective, including an analysis of policy options. Treating Drug Problems, Volume 2 provides important information to policy makers and administrators, drug treatment specialists, and researchers.

New Approaches to Drug Discovery

New Approaches to Drug Discovery
Author: Ulrich Nielsch
Publisher: Springer
Total Pages: 0
Release: 2016-04-08
Genre: Medical
ISBN: 9783319289120

This volume gives an overview of state of the art technologies and future developments in the field of preclinical pharmaceutical research. A balanced mix of experts from academia and industry give insight in selected new developments in the drug discovery pathway. The topics cover the different parts of the drug discovery process, starting with new developments in the target identification and validation area. The lead generation part as a next step focuses on the requirements and technologies to identify new small molecules as lead compounds for further optimization; in a second section the technologies to identify biologics as leads are addressed. The final part focuses on the pharmacological models and technologies to characterize new compounds and the impact of biomarkers to facilitate the transfer of drug candidates into the development phase.

Drug Policy and the Public Good

Drug Policy and the Public Good
Author: Thomas Babor
Publisher: Oxford University Press
Total Pages: 401
Release: 2018-07-04
Genre: Medical
ISBN: 0192550268

Illegal psychoactive substances and illicit prescription drugs are currently used on a daily basis all over the world. Affecting public health and social welfare, illicit drug use is linked to disease, disability, and social problems. Faced with an increase in usage, national and global policymakers are turning to addiction science for guidance on how to create evidence-based drug policy. Drug Policy and the Public Good is an objective analytical basis on which to build global drug policies. It presents the accumulated scientific knowledge on drug use in relation to policy development on a national and international level. By also revealing new epidemiological data on the global dimensions of drug misuse, it questions existing regulations and highlights the growing need for evidence-based, realistic, and coordinated drug policy. A critical review of cumulative scientific evidence, Drug Policy and the Public Good discusses four areas of drug policy; primary prevention programs in schools and other settings; supply reduction programs, including legal enforcement and drug interdiction; treatment interventions and harm reduction approaches; and control of the legal market through prescription drug regimes. In addition, it analyses the current state of global drug policy, and advocates improvements in the drafting of public health policy. Drug Policy and the Public Good is a global source of information and inspiration for policymakers involved in public health and social welfare. Presenting new research on illicit and prescription drug use, it is also an essential tool for academics, and a significant contribution to the translation of addiction research into effective drug policy.

Improving and Accelerating Therapeutic Development for Nervous System Disorders

Improving and Accelerating Therapeutic Development for Nervous System Disorders
Author: Institute of Medicine
Publisher: National Academies Press
Total Pages: 107
Release: 2014-02-06
Genre: Medical
ISBN: 0309292492

Improving and Accelerating Therapeutic Development for Nervous System Disorders is the summary of a workshop convened by the IOM Forum on Neuroscience and Nervous System Disorders to examine opportunities to accelerate early phases of drug development for nervous system drug discovery. Workshop participants discussed challenges in neuroscience research for enabling faster entry of potential treatments into first-in-human trials, explored how new and emerging tools and technologies may improve the efficiency of research, and considered mechanisms to facilitate a more effective and efficient development pipeline. There are several challenges to the current drug development pipeline for nervous system disorders. The fundamental etiology and pathophysiology of many nervous system disorders are unknown and the brain is inaccessible to study, making it difficult to develop accurate models. Patient heterogeneity is high, disease pathology can occur years to decades before becoming clinically apparent, and diagnostic and treatment biomarkers are lacking. In addition, the lack of validated targets, limitations related to the predictive validity of animal models - the extent to which the model predicts clinical efficacy - and regulatory barriers can also impede translation and drug development for nervous system disorders. Improving and Accelerating Therapeutic Development for Nervous System Disorders identifies avenues for moving directly from cellular models to human trials, minimizing the need for animal models to test efficacy, and discusses the potential benefits and risks of such an approach. This report is a timely discussion of opportunities to improve early drug development with a focus toward preclinical trials.

The Role of NIH in Drug Development Innovation and Its Impact on Patient Access

The Role of NIH in Drug Development Innovation and Its Impact on Patient Access
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
Total Pages: 103
Release: 2020-01-27
Genre: Medical
ISBN: 0309498511

To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24â€"25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.

Blueprint for a Public Health and Safety Approach to Drug Policy

Blueprint for a Public Health and Safety Approach to Drug Policy
Author: Tracy Pugh
Publisher:
Total Pages: 100
Release: 2013
Genre:
ISBN:

"The New York Academy of Medicine (NYAM) and the Drug Policy Alliance (DPA) are pleased to present this Blueprint for a Public Health and Safety Approach to Drug Policy. An independent organization since 1847, NYAM addresses the health challenges facing the world's urban populations through interdisciplinary approaches to policy leadership, innovative research, evaluation, education, and community engagement. DPA is the nation's leading organization promoting current drug policies that are grounded in science, compassion, health, and human rights. DPA and NYAM are organizations with very different missions and histories but a shared understanding that New York's current policy approach to drugs is failing. We joined together to examine New York's current drug policies and to reimagine how those policies could realize better health and public safety outcomes, through a more coordinated, public health-oriented approach based on the four pillars model of prevention, treatment, harm reduction, and public safety. Believing that good public policies should be developed in collaboration with those directly affected by them, we spent over a year holding community consultations across the state asking New York residents how drug use and drug policies affected them and their neighborhoods and what should be done to move the state forward. We also met with experts, policymakers, and service providers and conducted an extensive review of the literature. This Blueprint is the result of these research activities"--Academy website.